PubMed

Alzheimer-like changes in rat models of spontaneous diabetes.

Li ZG, Zhang W, Sima AA.

Diabetes. 2007 Jul;56(7):1817-24. Epub 2007 Apr 24. Erratum in: Diabetes. 2007 Oct;56(10):2650. PMID: 17456849 [PubMed - indexed for MEDLINE]Related articlesFree article

Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.

Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM.

J Alzheimers Dis. 2006 Mar;9(1):13-33.PMID: 16627931 [PubMed - indexed for MEDLINE]Related articles

Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway.

Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P.

J Neurochem. 2006 Feb;96(4):1005-15. Epub 2006 Jan 12.PMID: 16412093 [PubMed - indexed for MEDLINE]Related articles

Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.

Schmidt RE, Dorsey DA, Beaudet LN, Parvin CA, Zhang W, Sima AA.

J Neuropathol Exp Neurol. 2004 May;63(5):450-60.PMID: 15198124 [PubMed - indexed for MEDLINE]Related articles

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM.

J Alzheimers Dis. 2005 Feb;7(1):63-80.PMID: 15750215 [PubMed - indexed for MEDLINE]Related articles

The BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus.

Tirabassi RS, Flanagan JF, Wu T, Kislauskis EH, Birckbichler PJ, Guberski DL.

ILAR J. 2004;45(3):292-302. Review.PMID: 15229376 [PubMed - indexed for MEDLINE]Related articlesFree article

Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.

Moroz N, Tong M, Longato L, Xu H, de la Monte SM.

J Alzheimers Dis. 2008 Sep;15(1):29-44.PMID: 18780965 [PubMed - indexed for MEDLINE]Related articles

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin.

Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E.

J Neurosci Res. 2008 Nov 15;86(15):3265-74.PMID: 18627032 [PubMed - indexed for MEDLINE]Related articles

Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.

Pérez M, Morán MA, Ferrer I, Avila J, Gómez-Ramos P.

Acta Neuropathol. 2008 Oct;116(4):409-18. Epub 2008 Aug 5.PMID: 18679696 [PubMed - indexed for MEDLINE]Related articles

The role of impaired insulin/IGF action in primary diabetic encephalopathy.

Li ZG, Zhang W, Sima AA.

Brain Res. 2005 Mar 10;1037(1-2):12-24.PMID: 15777748 [PubMed - indexed for MEDLINE]Related articles

Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes.

Kamiya H, Murakawa Y, Zhang W, Sima AA.

Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):448-58.PMID: 15747389 [PubMed - indexed for MEDLINE]Related articles

Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.

Engel T, Hernández F, Avila J, Lucas JJ.

J Neurosci. 2006 May 10;26(19):5083-90.PMID: 16687499 [PubMed - indexed for MEDLINE]Related articlesFree article

A comparison of diabetic polyneuropathy in type II diabetic BBZDR/Wor rats and in type I diabetic BB/Wor rats.

Sima AA, Zhang W, Xu G, Sugimoto K, Guberski D, Yorek MA.

Diabetologia. 2000 Jun;43(6):786-93.PMID: 10907124 [PubMed - indexed for MEDLINE]Related articles

Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.

Kamiya H, Zhang W, Sima AA.

Diabetologia. 2006 Nov;49(11):2763-74. Epub 2006 Sep 20.PMID: 17047923 [PubMed - indexed for MEDLINE]Related articles

Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy.

Pierson CR, Zhang W, Murakawa Y, Sima AA.

J Neuropathol Exp Neurol. 2003 Mar;62(3):260-71.PMID: 12638730 [PubMed - indexed for MEDLINE]Related articles

High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice.

Thirumangalakudi L, Prakasam A, Zhang R, Bimonte-Nelson H, Sambamurti K, Kindy MS, Bhat NR.

J Neurochem. 2008 Jul;106(1):475-85. Epub 2008 Jul 1.PMID: 18410513 [PubMed - indexed for MEDLINE]Related articles

Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.

Henriksen EJ, Teachey MK.

Metabolism. 2007 Jul;56(7):931-8.PMID: 17570255 [PubMed - indexed for MEDLINE]Related articlesFree article

Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.

Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F.

Am J Pathol. 2008 Mar;172(3):786-98. Epub 2008 Feb 7.PMID: 18258852 [PubMed - indexed for MEDLINE]Related articlesFree article

Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.

van de Nes JA, Nafe R, Schlote W.

Brain Res. 2008 Jun 5;1213:152-65. Epub 2008 Apr 1.PMID: 18455153 [PubMed - indexed for MEDLINE]Related articles

Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.

Koh SH, Noh MY, Kim SH.

Brain Res. 2008 Jan 10;1188:254-62. Epub 2007 Nov 1.PMID: 18031715 [PubMed - indexed for MEDLINE]Related articles